Candriam S.C.A. Akoya Biosciences, Inc. Transaction History

Candriam S.C.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$5.28 - $8.35 $105,600 - $167,000	20,000 Added 7.8%	276,300 $2.04 Million
Q1 2023 May 12, 2023	BUY	$7.6 - $12.68 $714,400 - $1.19 Million	94,000 Added 57.92%	256,300 $2.1 Million
Q4 2022 Feb 13, 2023	SELL	$8.6 - $14.1 $77,400 - $126,900	-9,000 Reduced 5.25%	162,300 $1.55 Million
Q3 2022 Nov 10, 2022	BUY	$10.63 - $15.76 $127,560 - $189,120	12,000 Added 7.53%	171,300 $2.01 Million
Q1 2022 May 13, 2022	BUY	$9.84 - $14.97 $1.07 Million - $1.63 Million	109,000 Added 216.7%	159,300 $1.75 Million
Q4 2021 Feb 10, 2022	BUY	$11.37 - $15.31 $90,960 - $122,480	8,000 Added 18.91%	50,300 $770,000
Q3 2021 Nov 09, 2021	BUY	$13.04 - $21.0 $551,592 - $888,300	42,300 New	42,300 $590,000

12M

24.1K

Ticker AKYA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,892,300
Market Cap $111M
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.